Monitoring of PD-L1 expression on circulating immune cells of patients with small cell lung cancer (SCLC) receiving firstline treatment: Prognostic implications

被引：1
|
作者：
Papadaki, M. A. [1 ]
Nikolarakou, M-N. [1 ]
Vorrias, E. [2 ]
Kapetanaki, E-E. [1 ]
Kalapanida, D. [2 ]
Mavroudis, D. [2 ]
Agelaki, S. [2 ]
机构：
[1] UOC Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Greece
[2] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.181
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
150P
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
    Papadaki, M. A.
    Kapetanaki, E-E.
    Vorrias, E.
    Mavroudis, D.
    Agelaki, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1166 - S1166
  • [2] Association between very high PD-l1 expression versus high PD-l1 expression in patients receiving pembrolizumab as firstline treatment for advanced non-small cell lung cancer
    Shah, Syed Mohsin Mahmood
    Marmarelis, Melina
    Mamtani, Ronac
    Hubbard, Rebecca
    Hennessy, Sean
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 96 - 97
  • [3] PD-L1 Expression in Patients with Small Cell Lung Cancer
    Wang, Haiyue
    Li, Zhongwu
    Yang, Xin
    Zhou, Lixin
    Lin, Dongmei
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S818 - S818
  • [4] The Value of PD-L1 in Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Receiving Immunotherapy
    Xu, Y.
    Zhu, L.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S615 - S615
  • [5] Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer
    Acheampong, Emmanuel
    Abed, Afaf
    Morici, Michael
    Spencer, Isaacs
    Beasley, Aaron B.
    Bowyer, Samantha
    Asante, Du-Bois
    Lomma, Chris
    Lin, Weitao
    Millward, Michael
    Gray, Elin S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (03) : 440 - +
  • [6] PD-L1 Expression in Circulating Tumor Cells and Response to PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer Patients
    Guibert, N.
    Delaunay, M.
    Boubekeur, N.
    Rouquette, I.
    Lusque, A.
    Clermont, E.
    Fortoul, A.
    Farella, M.
    Favre, G.
    Pradines, A.
    Mazieres, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1997 - S1997
  • [7] PD-L1 Expression in Small Cell Lung Cancer
    Yasuda, Yuto
    Ozasa, Hiroaki
    Kim, Young Hak
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : E40 - E41
  • [8] PD-L1 expression in small cell lung cancer
    Komiya, Takefumi
    Madan, Rashna
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (13) : 1853 - 1855
  • [9] PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas
    Ilie, Marius
    Hofman, Veronique
    Long, Elodie
    Butori, Catherine
    Lalvee, Salome
    Selva, Eric
    Venissac, Nicolas
    Mouroux, Jerome
    Marquette, Charles Hugo
    Hofman, Paul
    CANCER RESEARCH, 2016, 76
  • [10] PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Dall'Olio, Filippo G.
    Gelsomino, Francesco
    Conci, Nicole
    Marcolin, Laura
    De Giglio, Andrea
    Grilli, Giada
    Sperandi, Francesca
    Fontana, Francesca
    Terracciano, Mario
    Fragomeno, Benedetta
    Tober, Nastassja
    Manferrari, Giulia
    Brocchi, Stefano
    Golfieri, Rita
    Fiorentino, Michelangelo
    Ardizzoni, Andrea
    CLINICAL LUNG CANCER, 2021, 22 (05) : 423 - 431
12345